Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by n-Lorem Foundation

n-Lorem Foundation Publishes Study Showing Targeted ASO Therapy Restores GBE1 Protein in APBD Patient Cells
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Celebrates Five Years of Bringing Hope and Potential Treatments to Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation’s Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for Treatment Options for People with Nano-rare Illnesses
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End
From n-Lorem Foundation
Via Business Wire
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations
From n-Lorem Foundation
Via Business Wire
Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Welcomes New Member Alan Lotvin to Its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024
From n-Lorem Foundation
Via Business Wire
n-Lorem Provides Update on Its Remarkable Progress to Deliver Hope and Potential Help to More Than 100 Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Unveils Limited Edition Holiday Ornament to Support its Mission to Provide Optimized ASO Therapies to Nano-rare Patients For Free, For Life
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Founder and CEO, Stanley Crooke, Named One of San Diego’s Most Influential People by the San Diego Business Journal
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Convenes First Annual Nano-rare Patient Colloquium to Share Accomplishments and Learnings in Developing Optimized ASO Therapies for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Collaborates to Support Children With Extremely Rare Diseases
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Founder and CEO, Stanley Crooke, M.D., Ph.D., Awarded the Steven C. Beering Award
From n-Lorem Foundation
Via Business Wire
n-Lorem Has Industrialized the Treatment of Nano-rare Patients and Formed Key Committees
From n-Lorem Foundation
Via Business Wire
n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem’s Patient Empowerment Program Approaches One Year Mark With More Than 5000 Episode Downloads
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Awarded Prestigious 2023 Edison Award
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Begins 2023 with More Than 80 Active Patient Programs
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Welcomes New Members, Paul Compton and Neil Shneider, to its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Launches New Website to Support its Nano-rare Patients, Treating Physicians and Institutions
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Initiates Clinical Trials for Three Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation CEO, Stanley Crooke, M.D., Ph.D., Chosen as 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien
From n-Lorem Foundation
Via Business Wire
SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families
From n-Lorem Foundation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS